ED
The startup develops rapid diagnostic kits for infectious diseases, focusing on point-of-care testing for tuberculosis and sexually transmitted infections using combinatorial and confirmatory methods. These kits enable early-stage diagnosis, allowing patients to receive timely and accurate results at the point of care.
Updated 18 months ago
Funding
$8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops rapid diagnostic kits for infectious diseases, focusing on point-of-care testing for tuberculosis and sexually transmitted infections using combinatorial and confirmatory methods. These kits enable early-stage diagnosis, allowing patients to receive timely and accurate results at the point of care.